QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,148 signal articles · 500 in last 24h · 103,980 total before filter · latest 34m ago
500last 24h
2495last 7d
474● bullish (7d)
247● bearish (7d)
198publishers
AllMacro218Earnings1485M&A144Regulatory15Product5Analyst29
✕ clear all filtersticker: ^GSPCsentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
HP (HPQ): Buy, Sell, or Hold Post Q1 Earnings?
StockStory12d agoneutral
HP (HPQ): Buy, Sell, or Hold Post Q1 Earnings?

HP has had an impressive run over the past six months as its shares have beaten the S&P 500 by 20.7%. The stock now trades at $25.12, marking a 29.3% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

Robert Half Q2 Earnings Call Highlights
MarketBeat12d agoneutral
Robert Half Q2 Earnings Call Highlights

Robert Half (NYSE:RHI) reported second-quarter 2026 revenue and earnings above the midpoint of its guidance, as management pointed to improving hiring demand in its Talent Solutions business but continued pressure at consulting subsidiary Protiviti from changes in the U.S. financial services regulat

Revolve (RVLV): Buy, Sell, or Hold Post Q1 Earnings?
StockStory12d agoneutral
Revolve (RVLV): Buy, Sell, or Hold Post Q1 Earnings?

Over the past six months, Revolve’s stock price fell to $25.36. Shareholders have lost 13.3% of their capital, which is disappointing considering the S&P 500 has climbed by 8.6%. This might have investors contemplating their next move.

Lilly Stock Is Rising on Plan to Seek Approval for Newest Weight-Loss Drug in 2027
Barrons.com13d agoneutral
Lilly Stock Is Rising on Plan to Seek Approval for Newest Weight-Loss Drug in 2027

Drugmaker Eli Lilly said Thursday that it is on track to seek federal approval for its next-generation obesity drug early next year. Lilly became the first drug company to reach a trillion dollar valuation last fall as sales of its weight loss drugs took off. Among adults with general obesity, the weekly injectable lowered the weight of late-stage trial participants by an average of 28% over 80 weeks at the highest doses tested.

Earnings: Negative cash flows make Big Tech more 'economically sensitive'
Yahoo Finance Video13d agoneutralVIDEO
Earnings: Negative cash flows make Big Tech more 'economically sensitive'

US stocks (^DJI, ^IXIC, ^GSPC) are selling off on Thursday as shares of Alphabet (GOOG, GOOGL) and Tesla (TSLA) sink lower after reporting negative cash flow on top of massive AI investments. Northwestern Mutual Wealth Management Company CIO Brent Schutte and Yahoo Finance Senior Reporter Brooke DiPalma comment on these post-earnings moves by both companies' stock.

T-Mobile Stock Falls. What’s Overshadowing Earnings Beat.
Barrons.com13d agoneutral
T-Mobile Stock Falls. What’s Overshadowing Earnings Beat.

T-Mobile US stock was sliding on Thursday after the wireless carrier reported softer-than-expected second-quarter revenue, overshadowing an earnings beat. T-Mobile reported adjusted earnings of $2.99, as revenue climbed 7.9% from a year ago to $22.8 billion. T-Mobile also said it now expects full-year adjusted free cash flow of between $18.4 billion and $18.8 billion, up from prior guidance of $18.1 billion to $18.7 billion.

S&P 500, Nasdaq close lower ahead of technology earnings
Reuters Videos13d agoneutralVIDEO
S&P 500, Nasdaq close lower ahead of technology earnings

<body><p>STORY: U.S. stocks ended lower on Wednesday, with Dow virtually flat, the S&P 500 dipping fractionally, while the Nasdaq lost more than half a percent.</p><p>Investors eagerly awaited earnings results after the closing bell from Alphabet and Tesla, the first of the Magnificent Seven megacaps to report.</p><p>Shares of Alphabet, down more than 1% at the close, dipped further in extended trading despite the Google parent topping Wall Street estimates for cloud revenue growth thanks to the AI boom.</p><p>And shares of Tesla, which also closed lower, tumbled another 2.5% in extended trading after Elon Musk's EV maker reported negative free cash flow for the first time in more than two years due to accelerated spending on AI infrastructure, battery capacity, robotaxis and next-generation manufacturing.</p><p>Bob Lang, founder and chief options analyst of Explosive Options, said that strong earnings are needed to keep the market moving higher.</p><p>“The one thing that has been pretty constant here for the past 4 or 5 months for the stock market has been strong earnings and certainly a first quarter brought us about 26, 27% earnings growth. So far in the second quarter, we're seeing it at about 16 to 17%. And that's without some of the big names that have reported for the second quarter yet. We're going to have big names like, Nvidia. We're going to have big names like Micron reporting in September. That's a couple of months away, of course. But you know, we're going to have some of these companies out there that are probably going to report some stellar earnings. And, it's really been the linchpin for keeping the stock market afloat right now.”</p><p>Shares of IBM rose in extended trading after the company cut its annual revenue growth forecast, days after shocking Wall Street with a warning that corporate spending was shifting toward AI-focused data-center gear at the expense of its software and mainframe computers.</p><p>:: ServiceNow Handout</p><p>And shares of ServiceNow, down about 6.5% at the close, rose more than 3% after hours as the company raised its forecast for annual subscription revenue for the second time after beating second-quarter revenue and profit estimates, driven by growing demand for its AI-powered software.</p><p>Among other tech names, shares of Super Micro Computer rallied almost 20%, making it the S&P 500's biggest percentage gainer, a day after the server maker said it had secured more than $60 billion in new orders in its fiscal fourth quarter.&nbsp;</p></body>